MS pharmacogenomics

In this online video lecture, Professor Oksenberg, reviews the current pharmacogenomics knowledge of MS, addressing DNA variants and gene expression signatures reported to correlate with therapeutic responses. He also explores the available options to incorporate pharmacogenomics into routine clinical practice.

His lecture was presented during the 2011 CME Annual meeting in multiple sclerosis MS: Evolving management in the new scenario, held May 6–7, in St Petersburg, Russia.

Learning objectives

After completing this video activity, participants will have a greater understanding of:

 

•  The current state of pharmacogenomic knowledge in MS
•  The correlation between therapeutic response and the DNA variants and gene expression signatures
•  The prospects for the incorporation of pharmacogenomics into routine clinical practice

Target audience

Physicians and healthcare professionals working in the field of multiple sclerosis

Instructions for participation

There are no fees for participating in this online activity.

All participants must complete the registration form to access the activity.